ImmuneOncia Therapeutics, Inc.

Research ImmuneOncia Therapeutics, Inc. (424870.KQ) on Bullrun: market cap KRW 278.38B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker424870.KQ
ExchangeKQ
CountrySouth Korea
SectorHealthcare
IndustryBiotechnology
CurrencyKRW
Market capKRW 278.38B
Financial periodQ2 2026
Net income-KRW 3.90B
Free cash flow-KRW 6.93B

Valuation Snapshot

latest market cap is KRW 278.38B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	KRW 278.38B	n/a	n/a	n/a

Dividend history

About ImmuneOncia Therapeutics, Inc.

ImmuneOncia Therapeutics, Inc., an immuno-oncology-centric biopharmaceutical company, develops immuno-oncology drugs for the treatment of cancer. It develops IMC-001, a human monoclonal antibody of the IgG1 type that targets PD-L1 an immunotherapy for cancer, which is in Phase II clinical trial for the treatment of NK/T cell lymphoma and solid cancer patients with high tumor mutation burden;

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

ORIENT BIO Inc. (002630.KS) GC Corp. (005250.KS) Pharmicell Co., Ltd. (005690.KS) Kanaph Therapeutics Inc. (0082N0.KQ) Samik Pharmaceutical Company LTD. (014950.KQ) HLB Co., Ltd. (028300) Mgen Solutions Co., Ltd. (032790.KQ) Daesung Microbiological Labs. Co., Ltd. (036480.KQ) Seoulin Bioscience Co.,Ltd. (038070.KQ) Hyundai Bioscience Co., Ltd. (048410.KQ) iNtRON Biotechnology, Inc. (048530.KQ) Synergy Innovation Co., Ltd. (048870.KQ)

Frequently asked questions

What is ImmuneOncia Therapeutics, Inc.'s market cap?

ImmuneOncia Therapeutics, Inc.'s market capitalization is KRW 278.38B.

What does ImmuneOncia Therapeutics, Inc. do?

ImmuneOncia Therapeutics, Inc., an immuno-oncology-centric biopharmaceutical company, develops immuno-oncology drugs for the treatment of cancer.